Published in Vopr Virusol on December 18, 1980
Antiviral and antitumor peptides from insects. Proc Natl Acad Sci U S A (2002) 1.17
Material for the study ofvariation in the Malayan Langat virus (TP-21 strain). Bull World Health Organ (1968) 1.14
Experience in the study of a live vaccine made from the TP-21 strain of Malayan Langat virus. Bull World Health Organ (1968) 0.95
[Monoclonal immunoenzyme test-system for evaluating secretory immunity to influenza A and B viruses]. Vopr Virusol (1998) 0.85
[Role of antineuraminidase antibodies in the human immunological response to the administration of live type A influenza vaccines]. Mikrobiol Zh (1981) 0.81
The importance of antineuraminidase antibodies in resistance to influenza A and immunologic memory for their synthesis. J Hyg (Lond) (1983) 0.81
[Antiviral activity of several vasodilator agents]. Biull Eksp Biol Med (1996) 0.81
[Humoral and cell-mediated immune responses in humans to the A/California/07/ 2009 (H1N1) virus, A(H1N1)pdm2009]. Vopr Virusol (2013) 0.79
Type A influenza (H2N2) viruses isolated in Leningrad in 1980. J Hyg (Lond) (1985) 0.79
[Indicators of collective immunity to influenza depending on the blood group and sex of the population]. Vopr Virusol (1989) 0.78
[Antibody functional activity in immunization with influenza vaccines]. Vopr Virusol (1994) 0.77
[Stimulation of homo- and heterologic T-cell immunological memory in volunteers inoculated with live influenza A (H5N2) reassortant vaccine]. Vopr Virusol (2012) 0.77
[Clinical picture and pathogenesis of progressive forms of experimental tick-borne encephalitis]. Zh Nevropatol Psikhiatr Im S S Korsakova (1972) 0.77
[The comparative characteristics of the safety, immunogenic activity and prophylactic potency of the adult and children types of live influenza vaccine in schoolchildren aged 7-14 years]. Vopr Virusol (2002) 0.77
[Prophylactic effectiveness of a live recombinant influenza type A vaccine in immunizing children aged 3-14 years]. Vopr Virusol (1996) 0.76
[Evaluation of mass influenza prevention effectiveness using an inactivated chromatographic vaccine in Leningrad]. Zh Mikrobiol Epidemiol Immunobiol (1980) 0.76
[Biological variants of the tick-borne encephalitis virus isolated in various foci of the disease]. Vopr Virusol (1975) 0.76
A new approach to development of live vaccine against tick-borne encephalitis. J Hyg (Lond) (1969) 0.75
[Protective effect of cycloferon in experimental influenza]. Vopr Virusol (2001) 0.75
[An experimental study of ADP-ribosylation inhibitors as anti-influenza agents]. Vopr Virusol (1992) 0.75
[Differences in vaccinal reactions associated with age in smallpox vaccinations]. Vopr Okhr Materin Det (1965) 0.75
New approach to development of live vaccine against tick-borne encephalitis. Arch Environ Health (1969) 0.75
[Immunomorphological changes in the mouse brain after intracerebral administration of a neurotropic strain of influenza virus]. Biull Eksp Biol Med (1991) 0.75
[Production of interleukin-2 in vitro and in vivo in elderly people, vaccinated with live and inactivated flu vaccines separately and combined]. Vopr Virusol (2000) 0.75
[The investigation of the safety, genetic stability and immunogenicity of live influenza vaccine for adults in vaccination of 3-6 years old children]. Vopr Virusol (2002) 0.75
[Specific immune response to vaccination with an inactivated flue vaccine depending on prevaccine status and age of the person vaccinated]. Vopr Virusol (2000) 0.75
[Therapeutic effect of methisazone in children with smallpox post-vaccine complications]. Pediatriia (1970) 0.75
[Complex study of population immunity to 3 influenza A virus antigens]. Zh Mikrobiol Epidemiol Immunobiol (1981) 0.75
[Antineuraminidase serum antibodies in natural influenza A and immunization with influenza vaccines]. Vopr Virusol (1983) 0.75
[The biological properties of virus-induced and mitogen-induced interferons in dogs]. Vopr Virusol (1991) 0.75
[Improved method of determining thermostable inhibitors in the blood serum]. Lab Delo (1980) 0.75
[Concept of the mechanism of the therapeutic effect of flu chemotherapy]. Dokl Akad Nauk (1992) 0.75
[Characteristics of 2 epidemic outbreaks of influenza in 1981]. Vopr Virusol (1984) 0.75
[The temperature sensitivity of epidemic influenza A viruses as a marker of immunogenicity of reassortant vaccinal strains]. Vopr Virusol (2003) 0.75
[Clinico-immunologic characteristics of different forms of complications following smallpox vaccination in children]. Zh Mikrobiol Epidemiol Immunobiol (1973) 0.75
[Course of influenzal infection in mice during the transfer of splenic cells from influenza-infected syngeneic donors]. Tr Inst Im Pastera (1982) 0.75
[Immune response to live influenza vaccine]. Vestn Ross Akad Med Nauk (2002) 0.75
[Results of virological and immunological studies in children with complications following smallpox vaccination]. Zh Mikrobiol Epidemiol Immunobiol (1970) 0.75
[Prevention of post-vaccination complications after primary smallpox vaccination of older children]. Pediatriia (1976) 0.75
[The evaluation of the reactogenicity and immunological activity of an inactivated 3-component influenza vaccine with an elevated hemagglutinin concentration in the inoculation dosage]. Zh Mikrobiol Epidemiol Immunobiol (1991) 0.75
[Humoral and local immune response to the influenza vaccine in people of old and young ages]. Vopr Virusol (2003) 0.75
[B-cell and cytotoxic lymphocyte immune response to virulent, attenuated and reassortant influenza viruses]. Vopr Virusol (2002) 0.75
[Studies on biological, reactogenic and immunogenic properties of a new variant of a live measles vaccine prepared from the Leningrad-5 strain]. Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol (1965) 0.75
[The use of saliva for study in the immunoenzyme analysis of postvaccinal and postinfectious immunity to influenza]. Vopr Virusol (1994) 0.75
[The frequency of development of associated infections in acute respiratory diseases]. Vopr Virusol (1974) 0.75
[Immunodiagnostic methods in interpreting an outbreak of respiratory syncytial virus infection]. Zh Mikrobiol Epidemiol Immunobiol (1990) 0.75
[Influenza morbidity in the Kazakh SSR 1977-1984]. Vopr Virusol (1986) 0.75
[Results of a study of collective immunity to influenza A virus (H1N1) from 1976 to 1980]. Vopr Virusol (1982) 0.75
[Dynamics of smallpox antibodies in children following vaccination and primary revaccination]. Zh Mikrobiol Epidemiol Immunobiol (1971) 0.75
[The role of antibody functional activity in the protection of people against influenza]. Vopr Virusol (1991) 0.75
[Stabilization of antiviral activity of porcine leukocytic interferon]. Vopr Virusol (1990) 0.75
[The protective effect of peptides from the thymus and tracheal mucosa in an experimental respiratory influenzal infection]. Zh Mikrobiol Epidemiol Immunobiol (1994) 0.75
[Age differences in the immunobiological reaction in infants in the 1st year of life vaccinated against smallpox]. Vopr Okhr Materin Det (1967) 0.75
[Regularities of formation in a general population of serum antibodies to previously circulated influenza A viruses]. Vopr Virusol (1990) 0.75
[The modelling of a persistent parainfluenza infection]. Vopr Virusol (1992) 0.75
[Characteristics of the state the population's immunity in the influenza epidemic of 1977-1978]. Zh Mikrobiol Epidemiol Immunobiol (1980) 0.75
[Formation and protective functions of antibodies to neuraminidase of the influenza A virus]. Vopr Virusol (1985) 0.75
[Local antibody immune responses in influenza patients and persons vaccinated with seasonal, pre-pandemic, and pandemic live attenuated influenza vaccines]. Vopr Virusol (2013) 0.75
[A trial of the preventive effect of methisazone upon smallpox vaccination of children with relative contraindications]. Zh Mikrobiol Epidemiol Immunobiol (1970) 0.75
[Relation of smallpox vaccination complications with infections caused by respiratory viruses]. Pediatriia (1972) 0.75
[Epidemiological surveillance of influenza based on research data on collective immunity]. Zh Mikrobiol Epidemiol Immunobiol (1986) 0.75
[Influenza vaccine stimulation of antibodies to different variants of influenza A virus]. Vopr Virusol (1985) 0.75
[Formation of humoral and secretory immunity in elderly persons with different schemes of immunization with flu vaccines]. Vopr Virusol (1998) 0.75
[The possibility of preparing a live vaccine against tick-borne encephalitis from Malay langat virus TP-21]. Tr Inst Im Pastera (1989) 0.75
[Immunoenzyme analysis of post-vaccination secretory immunity to influenza A and B viruses using a manufactured monoclonal immunoenzyme test system]. Vopr Virusol (1998) 0.75
[Virulogical and serological indices in children with different postvaccinal complications]. Vopr Okhr Materin Det (1969) 0.75
[Production and testing of lyophilized standard preparation for diagnosis of Mycoplasma pneumoniae infection by the indirect hemagglutination test]. Vopr Virusol (1978) 0.75
[Humoral antibody dynamics in children of various ages at long intervals following smallpox vaccination]. Vopr Virusol (1970) 0.75
Biologic and immunogenic properties of Langat TP-21 virus. Jpn J Med Sci Biol (1967) 0.75
[Effect of liposomal beta-carotene on experimentally lethal influenza infection]. Vopr Virusol (1999) 0.75
[Immune response of elderly persons depending on the number of annual seasonal immunizations of live and inactivated influenza vaccines]. Vopr Virusol (1998) 0.75
[Virological and serological diagnosis of influenza using the passive hemagglutination and passive hemagglutination inhibition tests]. Vopr Virusol (1987) 0.75
[Local immune response to live cold-adapted reassortant influenza vaccine in children, adults, and aged people]. Vopr Virusol (2003) 0.75
[Comparative study of the effectiveness of inactivated influenza vaccine preparations]. Zh Mikrobiol Epidemiol Immunobiol (1983) 0.75
[Immunologic characteristics of the vaccinal process in children with limited lesions of the central nervous system]. Zh Mikrobiol Epidemiol Immunobiol (1972) 0.75
[Production of virus-induced and mitogen-induced interferons by canine cells]. Vopr Virusol (1991) 0.75
[Problems for discussion in influenza A immunology]. Vopr Virusol (1981) 0.75
[Heterosubtypic immunity to influenza A viruses: epidemiological data, involvement of different immunological factors, vaccination]. Vopr Virusol (2012) 0.75
[Comparative study of the antiviral activity of rimantadine and bonafton]. Vopr Virusol (1977) 0.75
[Immunologic reactivity to smallpox vaccination in children with organic lesions of the central nervous system]. Zh Nevropatol Psikhiatr Im S S Korsakova (1974) 0.75
[The molecular mechanism of the action of antiviral preparations in the adamantane series]. Vestn Ross Akad Med Nauk (1993) 0.75
[Estimation of human and animal immunological memory by testing the trogocytosis of virus-specific T lymphocytes]. Vopr Virusol (2011) 0.75
[Immunological efficacy of smallpox vaccination in children with relative contraindications to vaccination]. Zh Mikrobiol Epidemiol Immunobiol (1975) 0.75
[Significance of the functional activity of antibodies in influenza immunity]. Vestn Ross Akad Med Nauk (1995) 0.75
[Effect of serum antiviral inhibitors on resistance to influenza and acute respiratory diseases]. Vopr Virusol (1973) 0.75
[Effect of nonspecific thermostabile inhibitors on the results of hemagglutination inhibition tests in the study of antivariola antibodies]. Lab Delo (1969) 0.75
[The immunoprophylaxis of influenza among elderly persons]. Zh Mikrobiol Epidemiol Immunobiol (1997) 0.75
[In vitro proliferative activity of lymphocytes from elderly persons after separate and combined immunization with live and inactivated flu vaccines]. Vopr Virusol (2000) 0.75
[Features of the formation of anti-smallpox immunity in children in infancy]. Zh Mikrobiol Epidemiol Immunobiol (1967) 0.75
[Nature of the "meta-influenza" stage of influenza]. Arkh Patol (1980) 0.75